Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC®)

被引:59
作者
Pachmann, K
Heiss, P
Demel, U
Tilz, G
机构
[1] LKH Univ Graz, Jean Dausset Lab, Gemeinsame Einrichtung Klin Immunol, Graz, Austria
[2] Lab Spezielle Immunhamatol & Gendiagnost, Bayreuth, Germany
关键词
solid tumours; minimal residual disease; laser scanning cytometry;
D O I
10.1515/CCLM.2001.134
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The detection of circulating tumour cells disseminated from solid tumours requires extremely sensitive methods. Molecular genetic methods, which are most sensitive, are not applicable to solid tumours because no tumour-specific genetic markers are available. Detection of disseminated tumour cells by immunocytochemistry is time-consuming, whereas fluorimetry is fast and quantitative. The laser scanning cytometer (LSC (R)) provides an automated microscopic procedure for screening Up to 5 x 10(4) cells in suitable time. Using this system together with an enrichment procedure which allows up to ten thousand-fold enrichment, we have quantified minimal numbers of tumour cells. In a model system, breast cancer cell line cells diluted into peripheral blood mimicked seeding of tumour cells into the periphery. After staining with fluorochrome-conjugated anti-epithelial antibody, slides were screened for positive events directly or after enrichment with antibody-coated magnetic beads. One positive cell was unequivocally detectable in 104 cells and 50 out of 60 tumour cells were reliably recovered from a 20 ml blood volume, equal to 1-2 cells per 10(7), after magnetic bead enrichment. This method allows quantitation of tumour cells in peripheral blood and bone marrow in reasonable time and will, for the first time, enable extensive investigation of the seeding behaviour of tumours.
引用
收藏
页码:811 / 817
页数:7
相关论文
共 29 条
[1]  
Braun S, 1999, INT J CANCER, V84, P1, DOI 10.1002/(SICI)1097-0215(19990219)84:1<1::AID-IJC1>3.0.CO
[2]  
2-A
[3]  
BRUGGER W, 1994, BLOOD, V83, P636
[4]   Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer [J].
Cooper, BW ;
Moss, TJ ;
Ross, AA ;
Ybanez, J ;
Lazarus, HM .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3509-3517
[5]   Laser-scanning cytometry: A new instrumentation with many applications [J].
Darzynkiewicz, Z ;
Bedner, E ;
Li, X ;
Gorczyca, W ;
Melamed, MR .
EXPERIMENTAL CELL RESEARCH, 1999, 249 (01) :1-12
[6]  
Fang BB, 1999, CYTOMETRY, V36, P294, DOI 10.1002/(SICI)1097-0320(19990801)36:4<294::AID-CYTO3>3.3.CO
[7]  
2-3
[8]   Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support [J].
Franklin, WA ;
Shpall, EJ ;
Archer, P ;
Johnston, CS ;
GarzaWilliams, S ;
Hami, L ;
Bitter, MA ;
Bast, RC ;
Jones, RB .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (01) :1-13
[9]  
Ghossein RA, 1996, CANCER-AM CANCER SOC, V78, P10, DOI 10.1002/(SICI)1097-0142(19960701)78:1<10::AID-CNCR3>3.3.CO
[10]  
2-T